News

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough ... In a recent interview with Fortune, Isomorphic Labs President Colin Murdoch said the company is “very close” ...
Isomorphic Labs, backed by Google's parent company Alphabet, is preparing for its first human clinical trials for cancer drugs designed entirely by artificial intelligence.
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...
A Isomorphic Labs, a drug discovery company driven by artificial intelligence (IA) and part of the A (holding of Google), is ...
Meta Platforms is racing to secure top artificial intelligence talent for its newly created Superintelligence Labs to better ...
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...
Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...
Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...
Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...
Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...
The new lab, set to include the Scale AI founder Alexandr Wang, is part of a reorganization of Meta’s artificial intelligence efforts under Mark Zuckerberg.